Tofacitinib in older patients with ulcerative colitis: balancing efficacy and safety
Intestinal Research · 30.04.2026 · 24 (2) · 193-194
DOI: 10.5217/ir.2026.00070 ↗Kurz gefasst
Editorial in der Zeitschrift Intestinal Research, erschienen am 30.04.2026. Verfasst von Yoon Suk Jung. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Zitieren
APA
Jung, Y. S. (2026). Tofacitinib in older patients with ulcerative colitis: balancing efficacy and safety. Intestinal Research, 24(2), 193-194. https://doi.org/10.5217/ir.2026.00070
Vancouver
Jung YS. Tofacitinib in older patients with ulcerative colitis: balancing efficacy and safety. Intestinal Research. 2026;24(2):193-194. doi:10.5217/ir.2026.00070
BibTeX
@article{Jung2026,
author = {Jung, Yoon Suk},
title = {Tofacitinib in older patients with ulcerative colitis: balancing efficacy and safety},
journal = {Intestinal Research},
year = {2026},
volume = {24},
number = {2},
pages = {193--194},
doi = {10.5217/ir.2026.00070}
}
EUVIMED